HR091506
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
October 03, 2025
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
(clinicaltrials.gov)
- P3 | N=765 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Jun 2025 ➔ Sep 2025 | Trial primary completion date: Nov 2024 ➔ Aug 2025
Trial completion • Trial completion date • Trial primary completion date • Gout • Inflammatory Arthritis • Rheumatology
August 29, 2025
A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Completed | N=18 ➔ 36
Enrollment change • Trial completion
July 25, 2025
A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial
May 15, 2024
Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
(clinicaltrials.gov)
- P3 | N=434 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P3 trial • Gout • Inflammatory Arthritis • Rheumatology
January 01, 2024
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
(clinicaltrials.gov)
- P3 | N=750 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Trial completion date • Trial initiation date • Trial primary completion date • Gout • Inflammatory Arthritis • Rheumatology
November 18, 2023
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
(clinicaltrials.gov)
- P3 | N=750 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P3 trial • Gout • Inflammatory Arthritis • Rheumatology
April 26, 2022
A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults
(clinicaltrials.gov)
- P1 | N=90 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial • Gout • Inflammatory Arthritis • Rheumatology
1 to 7
Of
7
Go to page
1